- Home
- EQR vs STE Comparison
EQR vs STE Comparison
Compare EQR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQR
- STE
- Stock Information
- Founded
- EQR 1993
- STE 1985
- Country
- EQR United States
- STE United States
- Employees
- EQR N/A
- STE N/A
- Industry
- EQR Real Estate Investment Trusts
- STE Industrial Specialties
- Sector
- EQR Real Estate
- STE Health Care
- Exchange
- EQR Nasdaq
- STE Nasdaq
- Market Cap
- EQR 27.9B
- STE 22.1B
- IPO Year
- EQR 1993
- STE 1992
- Fundamental
- Price
- EQR $75.29
- STE $218.88
- Analyst Decision
- EQR Buy
- STE Buy
- Analyst Count
- EQR 19
- STE 6
- Target Price
- EQR $75.22
- STE $253.00
- AVG Volume (30 Days)
- EQR 1.4M
- STE 737.0K
- Earning Date
- EQR 01-28-2025
- STE 11-06-2024
- Dividend Yield
- EQR 3.60%
- STE 1.04%
- EPS Growth
- EQR 35.67
- STE N/A
- EPS
- EQR 2.44
- STE 4.37
- Revenue
- EQR $2,940,829,000.00
- STE $5,325,525,000.00
- Revenue This Year
- EQR N/A
- STE $7.91
- Revenue Next Year
- EQR $4.01
- STE $6.37
- P/E Ratio
- EQR $30.81
- STE $36.82
- Revenue Growth
- EQR 3.33
- STE 15.75
- 52 Week Low
- EQR $57.33
- STE $195.50
- 52 Week High
- EQR $78.83
- STE $248.24
- Technical
- Relative Strength Index (RSI)
- EQR 53.04
- STE 47.10
- Support Level
- EQR $73.38
- STE $213.31
- Resistance Level
- EQR $78.32
- STE $218.38
- Average True Range (ATR)
- EQR 1.17
- STE 3.62
- MACD
- EQR 0.29
- STE 0.53
- Stochastic Oscillator
- EQR 47.67
- STE 62.18
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 299 apartment communities with around 80,000 units and is developing three additional properties with 977 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.